Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Businessweek Archives

Turning Off Renegade T Cells

Developments to Watch


The most effective way to treat autoimmune diseases such as multiple sclerosis is through drugs that suppress the immune system. But these drugs also leave patients at risk for infections.

Now, researchers are testing an alternative. Dr. Howard Weiner, co-director of the Center for Neurologic Diseases at Brigham & Women's Hospital in Boston, is trying to treat multiple sclerosis, rheumatoid arthritis, and other diseases by feeding patients certain proteins. In multiple sclerosis, for example, T cells -- the body's key defense against foreign invaders -- attack a myelin protein sheath on nerves. Weiner and Dr. David Hafler of Harvard University found that feeding animals a form of the myelin protein alleviated the disease. The scientists think oral ingestion of the right protein turns off the T cells, negating the immune system's attack. "The elegance of this approach is its specificity and lack of any unlikely side effects," says Hafler. It could also stave off rejection of transplanted organs. Results from human studies should be available within a year.EDITED BY PAMELA J. BLACK

blog comments powered by Disqus